期刊文献+

骶骨脊索瘤术后复发的相关因素分析 被引量:3

Analysis of recurrent factors of sacral chordoma
下载PDF
导出
摘要 [目的]探讨影响骶骨脊索瘤患者术后复发的相关因素。[方法]对1993~2008年间完成初次手术的28例骶骨脊索瘤病例进行随访,将患者术后CDFS期作为应变量,选取患者发病年龄、性别、肿瘤大小、部位、初次手术方式、有无局部浸润以及术后是否放疗等因素作为自变量,采用Kaplan-Meier法,Log-Rank法进行分析。[结果]28例患者随访时间平均为(76.2±47.2)个月,最后随访时共复发13例(46.4%),首次复发时间平均为(35.9±27.2)个月。Kaplan-Meier法单因素变量分析显示肿瘤部位、手术方式、有无局部浸润是影响骶骨脊索瘤患者术后复发的独立预测因素(P<0.05)。患者年龄、性别、肿瘤大小、术后是否放疗与复发无明显关系(P>0.05)。[结论]肿瘤部位高、手术切除不彻底和术前发生局部浸润患者复发率较高,术后CDFS期较短。扩大切除术有利于降低术后的复发率,延长术后CDFS期,术前仔细评估MRI有助于选择合理的手术方案。 [ Objective ] To retrospectively investigate recurrent factors of sacral chordoma after surgical treatment. [ Methods] This retrospective study included 28 patients with sacral chordoma who underwent primary operation from 1993 to 2008. The data on gender, age, tumor size, tumor location, invasion of the surrounding muscle, surgical type, and radiation therapy were reviewed. Continuous disease - free survival time (CDFS) was calculated according to the Kaplan - Meier method and statistical analysis was performed by using Log - Rank test. [ Results ] The mean follow - up time was 76.2 months. At the final follow - up, 13 of 28 patients (46.4%) developed local recurrences, and the average recurrence time was 35.9 months. Kaplan - Meier single factor analysis displayed that tumor location, invasion of the surrounding muscle, and surrgical type were the risk of the recurrence of sacral chordoma after surgical treatment (P 〈 0. 05) . CDFS had no significant difference between different age groups, sex groups, tumor size groups, and radiation therapies ( P 〉 0. 05 ) . [ Conclusion ] The higher level of tumor involvement, incomplete excision, and invasion into the surrounding muscles will probably lead to shorter CDFS. Tumor resection with wide surgical margins may have a better prognosis for these patients. Careful preoperative evaluation may help to plan reasonable operation.
出处 《中国矫形外科杂志》 CAS CSCD 北大核心 2009年第21期1613-1616,共4页 Orthopedic Journal of China
关键词 脊索瘤 骶骨 复发 手术治疗 持续无瘤生存期 chordoma sacrum recurrence surgery continuous disease - free survival time
  • 相关文献

参考文献12

  • 1Bergh P, Kindblom LG, Gunterberg B, et al. Prognostic factors in chordoma of the sacrum and mobile spine : a study of 39 patients [ J ]. Cancer, 2000,9:2122 - 2134.
  • 2Fuchs B, Dickey ID, Yaszemski MJ,et al. Operative management of sacral chordoma [J]. J Bone Joint Surg Am,2005,87:2211 -2216.
  • 3Hulen CA, Temple HT, Fox WP,et al. Oneologie and functional outcome following sacrectomy for sacral chordoma [J]. J Bone and Joint Surg Am,2006,7 : 1532 - 1539.
  • 4杨惠林,倪才方,唐天驷,洪天禄,许立,杨同其,徐耀增,包肇华,刘一之.靶血管栓塞后手术治疗骶骨肿瘤[J].中华骨科杂志,1998,18(11):646-648. 被引量:47
  • 5York JE, Kaczaraj A, Abi -Said D,et al. Sacral chordoma: 40 -year experience at a major cancer center [ J ]. Neurosurgery, 1999,44: 74 - 79.
  • 6Yonemoto T, Tatezaki SJ, Ishii T,et al. The surgical management of sacrococcygeal chordoma [ J ]. Cancer, 1999,4 : 878 - 883.
  • 7Thieblement C, Biron P, Rocher F,et al. Prognostic factors in chordoma : role of postoperative radiotherapy [ J ]. Eur J Cancer, 1995,31 : 2255 - 2259.
  • 8Akmal S, Ole SN, Anne GJ,et al. A retrospective clinicopatholo-cal study of 37 patients with chordoma: a Danish national series [ J ]. Sarcoma, 1997,1 : 161 - 165.
  • 9O' Connell JX, Renard LG, Liebsch NJ,et al. Base of skull chordoma. A correlative study of histologic and clinical features of 62 cases[ J]. Cancer, 1994,74 : 2261 - 2267.
  • 10Cheng EY, Ozerdemoglu RA, Transfeldt EE,et al. Lumbosacral chordoma :prognostic factors and treatment [ J ]. Spine, 1999,24 : 1639 - 1645.

二级参考文献23

  • 1李守强,徐微尘,李妹,崔东艳.术前动脉栓塞在骶骨肿瘤治疗中的价值[J].中国矫形外科杂志,2004,12(13):977-979. 被引量:15
  • 2米川,马忠泰,卢海霖,徐阳.球囊导管阻断动脉控制肿瘤术中出血的可行性研究[J].中华骨科杂志,2005,25(5):280-283. 被引量:33
  • 3倪才方,中华骨科杂志,1997年,17卷,427页
  • 4章祖成,中华骨科杂志,1997年,17卷,83页
  • 5徐万鹏,中华骨科杂志,1994年,14卷,67页
  • 6郭世绂,中华骨科杂志,1987年,7卷,330页
  • 7宋献文,中华骨科杂志,1983年,3卷,32页
  • 8Todd LT, Yaszeruski MJ, Currier BL,et al. Bowel and bladder function after major sacral resection[J]. Clin Orthop, 2002,397:36-39.
  • 9Wuisman P, Lieshout O, Sugihara S,et al. Total sacrectomy and reconstruction :oncologic and function outcome[ J]. Clin Orthop, 2000, 381 : 192 - 203.
  • 10Wuisman P, Lieshout O, Van Dijk M,et al. Reconstruction after total enbloc sacrifice for osteosarcoma using a custommade prosthesisl[ J]. Spine, 2001, 26:431-439.

共引文献53

同被引文献37

  • 1Ferraresi V, Nuzzo C, Zoccali C,et al. Chordoma : clinical characteris- tics,management and prognosis of a case series of 25 patients [ J ]. BMC Cancer,2010,10:22.
  • 2Tong AW, Stone MJ. Prospects for CIM0 - directed experimental therapy of human cancer [J]. Cancer Gene Ther,2003 ,1:1 - 13.
  • 3Yang HL,Zhu LF,Ebraheim NA,et al. Analysis of risk factors for recurrence after the resection of sacral chordoma combined with embolization [ J ]. Spine,2009,12 : 972 - 980.
  • 4Sumpio BE ,Yun S,Cordova AC ,et al. MAP kinases (ERK1/2 ,p38) and AKT can be phosphorylated by shear stress independently of PE- CAM - 1 ( CD31 ) in vascular endothelial cells [ J]. J Biology Chem- istry,2005,12:11185 - 11191.
  • 5Wippold FJ 2^nd, Koeller KK, Smimiotopoulos JG. Clinical and ima- ging features of cervical chordoma[ J]. AJR, 1999,5:1423 - 1426.
  • 6Bohlman HH, Sachs BL, Carter JR,et al. Primary neoplasms of the cervical spine. Diagnosis and treatment of twenty - three patients [ J]. J Bone Joint Surg Am, 1986,68:483 -494.
  • 7Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its re- ceptors[ J]. Nat Med, 2003,9:669 - 676.
  • 8Fonsatti E, Sigalotti L, Arslan P, et al. Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in hu- man malignancies [ J ]. Curt Cancer Targets,2003,6:427 - 432.
  • 9Lu CD, Ahieri DC, Tanigawa N. Expression of a novel anti - apop- tosis gene, Surviv in, correlated with tumor cell apoptosis and P53 accumulation in gastric carcinomas[ J]. Cancer Res, 1998,9 : 1808 - 1812.
  • 10Mattern J, Koomagi R, Volm M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid lung cancer [ J ]. Br J Cancer, 1996,73:931 - 934.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部